The Fifth Circuit Court’s ruling, which is being appealed, reinstates a requirement that patients visit a health care provider in person to obtain mifepristone, upending abortion access in the United States.
Advertisement
Via New York Times
Read original article
Comments (0)
Add a Comment
No comments yet